Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,942.6 | 156.81 | 4,61,644.04 | 608.7 | 0.83 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 7,188.5 | 69.13 | 1,84,053.35 | 756 | 0.43 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,973.5 | 75.69 | 1,67,464.5 | 467 | 0.77 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,438.1 | 33.49 | 1,15,263.37 | 384.64 | 0.91 | 3,840.92 | 423.36 |
Lupin Ltd LUPIN | 2,469.2 | 18.94 | 1,14,205.26 | 2,163.69 | 0.72 | 5,152.26 | 659.04 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.